Pfizer Inc. is recalling 10.1 kilograms of Testosterone Propionate Micronized USP, an active pharmaceutical ingredient (API) used in veterinary medicines. The recall was initiated because the product may be contaminated with testosterone, which could affect the potency or composition of finished medications. This affected batch was manufactured by Pharmacia & Upjohn Company in Kalamazoo, MI, and distributed to several states for further processing or use in veterinary treatments.
The presence of unintended testosterone in a testosterone propionate API can lead to incorrect dosing or unintended hormonal effects in the animals receiving the final medication. Contamination can compromise the safety and efficacy of the pharmaceutical products derived from this specific batch of raw material.
Veterinary Drug Recall Refund/Consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response